Optometrists in Okemos, MI Accepting Medicare

26 Optometrists found. Showing 21 - 26

Rx Optical Laboratories, Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2285 W Grand River Ave, Okemos, MI 48864 Phone: 517-349-9944

Lori L. Comparoni, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 5100 Marsh Rd Ste H, Okemos, MI 48864 Phone: 517-349-0150    Fax: 517-349-0157

Capital City Vision Pc Optometrist Medicare: Medicare Enrolled Practice Location: 1865 W Grand River Ave, Okemos, MI 48864 Phone: 517-349-2393    Fax: 517-349-3751

Meridian Eye Care, Pc Optometrist Medicare: Medicare Enrolled Practice Location: 1669 Hamilton Rd, Ste 200, Okemos, MI 48864 Phone: 517-349-4743    Fax: 517-349-0096

Svs Vision Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4930 Marsh Rd, Space #5, Okemos, MI 48864 Phone: 517-709-8010    Fax: 517-709-8049

Lindsey Leah Hood Optometrist Medicare: Medicare Enrolled Practice Location: 2080 Hamilton Rd, Okemos, MI 48864 Phone: 517-349-8888

News Archive

Alternatives exist to eliminate nonmedical exemptions for childhood vaccination

For more than 30 years, Mississippi and West Virginia were the only states in the country that disallowed nonmedical exemptions to mandatory school vaccination laws for religious or philosophical reasons, until they were joined by California last year. These exemption laws have provoked debate over the rights of parents versus the responsibility of government to protect public health.

The 7th annual World Stem Cell Summit takes place in Pasadena, CA

Stem cell research and regenerative medicine has long held the potential to treat serious medical conditions, but only recently has the industry as a whole begun to take shape. What was once confined within the realm of research and academia is now attracting the interest of corporations and philanthropists who are investing large amounts of money into this promising science.

Mylan confirms first-to-file patent challenge relating to Xeloda

Mylan Inc. has confirmed that the company and its subsidiary Mylan Pharmaceuticals Inc. have been sued by Hoffmann-La Roche Inc. in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Capecitabine Tablets, 150 mg and 500 mg, the generic version of Xeloda Tablets, a chemotherapy treatment for breast and colorectal cancer.

Hydroxyurea may prevent complications such as organ damage and stunted growth in treatment of sickle cell disease

Treating babies who have sickle cell disease (SCD) with oral liquid hydroxyurea appears to prevent the onset of long-term complications triggered by this disease, according to results of a preliminary study by investigators at St. Jude Children's Research Hospital.

Read more Medical News

› Verified 2 days ago

• 1
• 2(current)